Home >  Registry
     
 
 Protocol Registry Trial Results IFPMA Background Links
About this Registry

This registry serves as a global repository for information on ongoing Roche Pharmaceuticals Phase II to Phase IV clinical studies, Phase I studies in patients and Roche Diagnostics interventional studies on advanced diagnostic products.

For More Information 

Common Questions
More Frequently Asked Questions 
Overview of Clinical Trials 
Glossary of Terms 
Phase Definitions 
Field Definitions 
Roche Clinical Trial Global Policy 
Site Provided by Thomson CenterWatch

Kidney Transplantation

  • CONCEPT study - A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Recipients
    No longer recruiting


  • CLEAR study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants
    No longer recruiting


  • OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.
    No longer recruiting


  • Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients
    No longer recruiting


  • A Study of the Correlation Between Pharmacokinetic and Pharmacodynamic Parameters of CellCept (Mycophenolate Mofetil).
    No longer recruiting


  • Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation
    Completed


  • Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.
    Completed


  • A Study of the Effect of CellCept (Mycophenolate Mofetil) on Renal Function After Withdrawal of Cyclosporine in Kidney Transplant Patients
    Completed


  • A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients
    Completed


  • A Study to Assess Immune Response in Pediatric Kidney Transplant Recipients Treated With Zenapax (Daclizumab)
    Completed


  • A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients
    Completed


  • A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients With Impaired Renal Function
    Completed


  • A Study of a Steroid Sparing Regimen in Combination With CellCept, Zenapax and Sirolimus in the Prevention of Acute Renal Allograft Rejection.
    Terminated


  • A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients Switched From EC-MPS.
    Terminated


    		•

    © 1996-2008 F.Hoffmann-La Roche Ltd See our legal Statement